CRVS and REGN Related Headlines

Go Back

Apr 20, 2026 07:30AM Goldman Sachs sees nearly 140% upside in this biopharma stock
Apr 13, 2026 05:52AM Bernstein on US Pharma and Biotech: Who might buy whom?

CRVS and REGN Related Press Releases

Go Back

CRVS and REGN Related SEC Filings

Go Back